Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab175612-100μg
|
100μg |
10
|
$99.90
|
|
|
Ab175612-1mg
|
1mg |
4
|
$479.90
|
|
|
Ab175612-5mg
|
5mg |
1
|
$1,669.90
|
|
|
Ab175612-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$2,669.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Nimotuzumab (anti-EGFR) - Primary antibody, specific to EGFR, >95%, high purity, Human IgG1, INHIBITOR of Epidermal growth factor receptor erbB1 inhibitor |
|---|---|
| Synonyms | Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody | Cell growth inhibiting protein 40 antibody | Cell proliferation inducing protein 61 antibody | EGF R antibody | EGFR antibody | EGFR_HUMAN antibody | Epidermal growth factor recepto |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | EGFR |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Epidermal growth factor receptor erbB1 inhibitor |
| Product Description |
Nimotuzumab (anti-EGFR) is a humanized IgG1 monoclonal antibody targeting EGFR with a KD of 0.21 nM. Nimotuzumab (anti-EGFR) is directed against the extracellular domain of the EGFR blocking the binding to its ligands. Nimotuzumab (anti-EGFR), a strong antitumor agent, is cytolytic on target tumors by its capacity to cause antibody dependent cell mediated cytotoxicity (ADCC) and complement dependent cytotoxicity (CDC)[1][2]. |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | kappa |
| SDS-PAGE | 26.8 kDa (Light Chain) & 51.6kDa (Heavy Chain), under reducing conditions; 189.1 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 780758-10-3 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Nimotuzumab (anti-EGFR) (Ab175612) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Nimotuzumab (anti-EGFR) (Ab175612). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nimotuzumab (anti-EGFR) (Ab175612) - Flow Cytometry
Flow Cytometry analysis of Hela cells labelling EGFR (red) with Nimotuzumab (anti-EGFR) (Ab175612). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Nimotuzumab (anti-EGFR) (Ab175612) - SEC
The purity of Nimotuzumab (anti-EGFR) (Ab175612) is more than 95% verified by HPLC.
Nimotuzumab (anti-EGFR) (Ab175612) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Nimotuzumab (anti-EGFR) (Ab175612) with the EC50 of 45.18 ng/mL.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Apr 01, 2024 | Ab175612 | |
| Certificate of Analysis | Apr 01, 2024 | Ab175612 | |
| Certificate of Analysis | Apr 01, 2024 | Ab175612 |
Starting at $49.90
Starting at $59.90
Starting at $69.90
Starting at $109.90
Starting at $69.90
Starting at $59.90
Starting at $59.90
Starting at $54.90
Starting at $56.90
Starting at $49.90
Starting at $89.90
Starting at $59.90
Starting at $59.90
Starting at $49.90